Post-coital gross hematuria: an unusual presentation of benign prostatic hyperplasia.
- Author:
Yi-Hong CHEN
1
;
Pei-Yu LIN
;
Yu-Sheng CHENG
;
Johnny Shinn-Nan LIN
;
Yung-Ming LIN
Author Information
- Publication Type:Case Reports
- MeSH: 5-alpha Reductase Inhibitors; Azasteroids; therapeutic use; Coitus; physiology; Dutasteride; Enzyme Inhibitors; therapeutic use; Hematuria; drug therapy; etiology; physiopathology; Humans; Male; Middle Aged; Prostatic Hyperplasia; complications; diagnosis; physiopathology; Urinary Tract
- From: Asian Journal of Andrology 2007;9(6):856-858
- CountryChina
- Language:English
-
Abstract:
AIMTo describe an unusual symptom of benign prostatic hyperplasia (BPH).
METHODSA patient presented to our urology clinic having experienced post-coital gross hematuria for 2 years. He had not experienced lower urinary tract symptoms (LUTS). A series of examinations were performed to determine the source of bleeding.
RESULTSThe prostate was defined as the active bleeding source responsible for the patient's post-coital hematuria. Endoscopic fulguration did not alleviate the symptom. The use of dutasteride, a dual inhibitor of 5alpha-reductase, solved the problem.
CONCLUSIONThis study reports for the first time that post-coital gross hematuria is one of the clinical presentations of BPH, which can be successfully treated with 5alpha-reductase inhibitor.
